What Humana’s BlackRock Deal, Village Medical’s Divestitures Signal For Older Adult Primary Care

Humana (HUM) is forming a joint venture with BlackRock to own 150 CenterWell clinics, valued at $2.8B. BlackRock will hold majority ownership, with Humana retaining minority. The deal, expected to close in Q4 2026, will reduce Humana's liabilities and support clinic expansion. Humana's 2026 earnings guidance remains at least $9 per share.

AngioDynamics announced that Humana updated its Medicare Advantage coverage policy to include NanoKnife IRE for prostate and liver cancer, effective October 1, 2026. This follows recent reimbursement milestones, including new CPT codes and Palmetto GBA's LCD L40205. Humana, with 7 million members, will use LCD L40205 criteria for coverage, subject to prior authorization.

BlackRock's HPS credit arm is lending $2.8 billion to Humana, entering a market previously dominated by Apollo's 'capital solutions' business. Apollo has made large loans to companies like Intel and Keurig Dr Pepper, earning $800 million last year. Both firms are competing to provide corporate credit solutions.

AngioDynamics (ANGO) announced Humana's updated Medicare Advantage coverage policy for its NanoKnife System, effective October 1, 2026. The policy applies LCD L40205 criteria for IRE technology, covering eligible patients with intermediate-risk prostate cancer and certain liver tumors. This follows recent reimbursement milestones, including CPT codes and Palmetto GBA's LCD. Humana, with 7 million members, will use LCD L40205 criteria for consistent coverage.

Humana (HUM) announced a partnership with BlackRock (BLK) to manage 150 CenterWell Senior Primary Care clinics. BlackRock will acquire a $2.8B stake, taking majority ownership. The deal aims to expand operations and is expected to close in Q4 2026. Humana's stock is trading at $420.38, with a GF Value™ of $382.31, indicating a 10% overvaluation. The company has a GF Score™ of 83/100, reflecting strong growth and profitability.

Humana (HUM) expects 95% of its Medicare members to be in four-star or better plans in 2027, up from 20% previously. This could lead to an estimated $4.8 billion bonus from the government in 2028, though the money may be used to improve benefits rather than boost profits. The stock has risen 112% in six months, trading at 24.33 times next year's expected earnings.